Iovance Biotherapeutics Inc

Financials

Activos totales 768.46 M777.33 M663.98 M780.35 M910.43 M913.17 M Total de pasivos 111.96 M155.67 M164.34 M195.74 M200.02 M214.59 M Capital total 656.5 M621.66 M499.64 M584.61 M710.4 M698.58 M Total de pasivos y patrimonio neto 768.46 M777.33 M663.98 M780.35 M910.43 M913.17 M Deuda total —1 M1 M1 M1 M49.44 M Deuda neta —-503.41 M-470.85 M-278.87 M-322.78 M-247.54 M

Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer.

IOVA

Financials

Iovance Biotherapeutics Inc

Noticias

Undercovered Stocks: Zscaler, Aeluma, Devon Energy, And More

Jefferies reitera calificación de compra para acciones de Iovance Biotherapeutics

Iovance Biotherapeutics: Positioned For Multi-Year Growth, Buy The Pullback (NASDAQ:IOVA)

Iovance Biotherapeutics: Competition Afoot, But New Indications Can Help (NASDAQ:IOVA)

Iovance Biotherapeutics (IOVA) Down 2.1% Since Last Earnings Report: Can It Rebound?

Eton Pharmaceuticals (ETON) Soars 6.7%: Is Further Upside Left in the Stock?

Wendy Yarno, miembro de la junta de Iovance Biotherapeutics, se retirará tras su mandato actual

Iovance Biotherapeutics en la Conferencia de Barclays: Crecimiento estratégico y desafíos

Iovance Biotherapeutics en Conferencia Barclays: Crecimiento y Desafíos

Iovance Biotherapeutics at Barclays Conference: Strategic Growth and Challenges

What's Going On With Iovance Biotherapeutics Stock On Friday? - Iovance Biotherapeutics (NASDAQ:IOVA)

Las acciones de Iovance Biotherapeutics alcanzan un máximo de 52 semanas en 4,35 dólares